| Product |
Tests
|
|---|---|
| Description of Project |
This investment will enable Hologic, Inc. to expand production capacity for COVID-19 tests in their supplier’s facilities, increasing their production capacity to 13 million COVID-19 tests per month by January 2022. |
| Unique Impact |
This investment will enable Hologic to improve the supply to laboratories across the country in addition to scaling up employment in Hologic supplier facilities and support the demand for COVID-19 testing in the United States. |
| Base Award Amount |
$7,506,725.76
|
| Category |
Testing Capacity and Raw Materials
|